Main Article Content
Background:Clinical Disease Activity Index (CDAI) stands out amongst other methods in measuring disease activity of rheumatoid arthritis (RA) patient. CDAI is considered to be more practical and cost-effective in daily practice because it requires no laboratory
examination. Previous studies conducted overseas revealed that CDAI has good correlation compared to other scoring index in measuring RA disease activity. However, those studies only included pure RA patients without any comorbidity diseases. Indonesian RA patients have distinct clinical profile, in terms of comorbidity conditions, and genetic predisposition which affect the fenotype of the disease.
Objectives: Analyze correlation between CDAI compared to Disease Activity Score 28 CRP (DAS28- CRP) in measuring RA disease activity of RA patients in Indonesia.
Methods: We conducted a cross sectional study to RA patients who visited rheumatology clinic at Cipto Mangunkusumo general hospital from April to May 2016. Data collected included history of illness, physical examination, and recent laboratory results. All data were documented in reseachâ€™s form. Both CDAI and DAS28- CRP were measured in each patient by two observers. Correlation analysis between two numeric datas from
CDAI and DAS28-CRP were measured with Spearmanâ€™s Rho. Overall performance was analyzed as additional results using R2 index.
Result: A total of 119 subjects were included in this study. All subjects were RA patients with comorbidities and were representing quite numbers of Indonesian races characteristic profile. Spearmanâ€™s Rho = 0,918 and R2 index =0,831 (83,1%).
Conclusion: There is positive correlation result between outcome of CDAI and outcome of DAS28-CRP in assesing disease activity of Indonesian RA patients.
Key Word: rheumatoid arthritis, Indonesia, correlation,Clinical Disease Activity Index.
This work is licensed under a Creative Commons Attribution 4.0 International License.
- Anderson J, Caplan L, Yazdany J, Robbins M, Neogi T, Michaud K. et al Rheumatoid Arthritis Disease Activity Measures: American College of Rheumatology Recommendations for Use in Clinical Practice. Arthritis Care Res. 2012;65(5):640-7.
- Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W. Disease activity assesement of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the disease activity score including 28 Joints (DAS28) compared with clinical disease activity index (CDAI). Clin Exp Rheumatology. 2009;27(4):552-9.
- Alateha D, Nell V, Stamm T, Uffman M. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Journal of Arthritis Res Ther.2005;7(4):796-806.
- Singh H, Kumar H, Handa R, Talapatra P, Ray S, Gupta V. Use of clinical disease activity index score for assessment of disease activity in rheumatoid arthritis Patients: an indian experience . Arthritis;2011;1-5
- Martins F, Silva JAP, Santos M, Sousa E, Duarte C, Santos H et al. DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the rheumatic diseases portugese register reuma pt. Rheumatology. 2015;54: 286â€“91.
- Ghosh A, Ghosh B, Pain S, Pande S, Pande A, Saha S. Comparison between DAS 28, CDAI and HAQ-DI as tools to monitor early rheumatoid arthritis patients in eastern india. Indian J Rheumatol. 2011;6(3):116-22.
- Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS. Assesing remission in clinical practice. Rheumatology 2007;46(6):975-9.
- Gorial F. Validity and reliability of CDAI in comparison to DAS28 in iraqi patients with active rheumatoid arthritis. J Fac Med. 2012;54(3).231-3.
- Maria M, Oliveira B, Cerqueira J, Quixada R, Oliveira I. Correlation of rheumatoid arthritis activity indexes (disease activity score-28 measured with ESR and CRP, simplified disease activity index and clinical disease activity index) and agreement of disease activity states with various cut-off points in a orthern brazilian population. Rev Bras Reumatol. 2015;55(6):477-84.
- Slama I, Allali F, Hajjaj N. Reliability and validity of CDAI and SDAI indices in comparison to DAS-28 index in moroccan patients with rheumatoid arthritis. BMC Musculoskelet Disord. 2015;29(16):268-73.
- Heijde D. Professor at Department of Rheumatology Leiden University Medical Center. Personal communication. 29th January 2015.
- Darmawan J, Muirden KD, Valkenburg HA. Wigley RD.The epidemiology of rheumatoid arthritis in indonesia. Br J Rheumatol.1993;32(7):537-40
- Soeroso J, Konthen P, Judajana FM, Kalim H, Smith A, Nelson JL. Balancing selection of HLA class II among indonesians. Indonesian J Clin Pat Med Lab. 2012;18(3):1-7.
- Riset kesehatan dasar (Riskesdas) 2013. Jakarta: Badan Litbangkes Departemen Kesehatan Republik Indonesia.2013.
- Anderson L, Dean A, Falzon D, Floyd K, Baena IG, Gilpin C, et al. World health organization global tuberculosis report 20th edition. 2015.
- Waldeburger J, Firestein G. Rheumatoid arthritis: epidemiology, pathology and pathogenesis. In: Klippel , J. Stone J, Crofford L, White P. Primer on The Rheumatic Disease 13th Edition. New York: Springer; 2008.p: 122-32.
- Ling S, Viatte S, Lunt M, Sijl A, Fernandez L, Symmons D, et al. HLA-DRB1 amino acid position 11/13, 71 and 74 are associated with inflammation level, disease activity and the health asessment questionnaire disability index in patients with inflammatory polyarthritis. Arthritis Rheumatol.2016;68(11):2618-28.
- Chandrasekaran AN, Radhakrishna B. Rheumatoid arthritis and connective tissue disorder in india and southeast asia. Bailieres Clin Rheumatology.1995;9(1):45-57.
- International Diabetes Federation. Diabetes atlas sevent edition. Available from: http://www.idf.org/idf-diabetes-atlas-seventh-edition [Accessed 3rd April 2016].
- Barnhart HX, Haber MJ, Lin LI. An overview on assesing agreement with continous measurement. J Biopharm Stat. 2007;17(4):529-69.
- Sastroasmoro S, Ismael S. Dasar-Dasar Metodologi Penelitian Klinis Edisi Ketiga. Jakarta:Sagung Seto;2010.p:58-78.
- Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of predictions models: a framework for some traditional and novel measures. Epidemiology.2010;21(1):128-38.
- Hutcheson GD. Ordinary least-squares regression. In: Moutinho L, Hutcheson GD (eds.). The SAGE Dictionary of Quantitative Management Research. London: SAGE Publishing;2011:p.224-8.
- Nishishiba M,Jones M, Kraner M. Research Methods and Statistics for Public and Nonprofit Administrators: A Practical Guide. London: SAGE Publishing;2011.
- Tompkins CA. Using and interpreting linear regression and correlation analysis: some cautions and considerations. Clin Aphasiology.1992;21:35-46.
- Grobbee DE, Hoes AW. Clinical Epidemiology: Principles, Methods and Applications for Clinical Research. Jones and Bartlett Publishers:2009.p:340-3.
- Desiree van der Heijde M, Martin A, van Hoff M, van Riel P, Theunisse L, Lubbert E.. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity. Ann Rheum Dis. 1990;49(11):916-20.
- Van Riel P, van Gastel A, Van De Putte B. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol. 1996 Sep;35(2):4-7.
- Baker J, Conaghan P, Smolen J, Aletaha D, Shults J, Emery P et al. Development and validation of modified disease activity scores in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(4):794-802.
- Lipsky P. Rheumatoid arthritis. In: Fauci A, Kasper D, Longo D, Braunwald E, Hauser S, Jameson J, Loscalzo J. (eds.) Harrisonâ€™s rheumatology second edition. New York: McGraw Hill; 2010.p:82-83.
- Harris E, Firestein G. Clinical features of rheumatoid arthritis. In: Firestein G, Budd R, Harris E, Melness I, Ruddy S, Sergent J. (eds.). Kellyâ€™s Textbook of Rheumatology Eight Edition. Philadelphia: Elsevier; 2009.p: 1087-115.